Robert Andrade

CIK: 0001468308

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (2.3%)

Position reduction

Option Exercises (M)13 (30.2%)

Derivative conversions

Awards (A)29 (67.4%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

FENC

FENNEC PHARMACEUTICALS INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (43 total)

FENC
FENNEC PHARMACEUTICALS INC.
Oct 31, 2026
Award(A)
Direct
1.7K shares-
FENC
FENNEC PHARMACEUTICALS INC.
Oct 12, 2026
Award(A)
Direct
3.8K shares at avg. $5.53$21K
FENC
FENNEC PHARMACEUTICALS INC.
Sep 30, 2026
Award(A)
Direct
1.7K shares-
FENC
FENNEC PHARMACEUTICALS INC.
Aug 28, 2026
Exercise(M)
Direct
21.9K shares at avg. $5.10$112K
FENC
FENNEC PHARMACEUTICALS INC.
Aug 27, 2026
Sale(S)
Direct
75K shares at avg. $11.78$884K
FENC
FENNEC PHARMACEUTICALS INC.
Jul 31, 2026
Award(A)
Direct
1.7K shares-
FENC
FENNEC PHARMACEUTICALS INC.
Jun 30, 2026
Award(A)
Direct
1.7K shares-
FENC
FENNEC PHARMACEUTICALS INC.
May 31, 2026
Award(A)
Direct
1.7K shares-
FENC
FENNEC PHARMACEUTICALS INC.
Apr 30, 2026
Exercise(M)
Direct
1.7K shares-
FENC
FENNEC PHARMACEUTICALS INC.
Mar 31, 2026
Award(A)
Stock Options
Direct
120K shares at avg. $5.77-
FENC
FENNEC PHARMACEUTICALS INC.
Mar 31, 2026
Exercise(M)
Direct
2.2K shares-
FENC
FENNEC PHARMACEUTICALS INC.
Mar 31, 2026
Exercise(M)
Direct
14.7K shares-
FENC
FENNEC PHARMACEUTICALS INC.
Mar 28, 2026
Exercise(M)
Direct
12.3K shares-
FENC
FENNEC PHARMACEUTICALS INC.
Mar 26, 2026
Exercise(M)
Direct
13.1K shares at avg. $5.10$67K
FENC
FENNEC PHARMACEUTICALS INC.
Feb 28, 2026
Award(A)
Direct
1.2K shares-
FENC
FENNEC PHARMACEUTICALS INC.
Feb 18, 2026
Exercise(M)
Direct
2.5K shares at avg. $4.08$10K
FENC
FENNEC PHARMACEUTICALS INC.
Feb 18, 2026
Exercise(M)
Direct
27.3K shares-
FENC
FENNEC PHARMACEUTICALS INC.
Jan 31, 2026
Award(A)
Direct
1.6K shares-
FENC
FENNEC PHARMACEUTICALS INC.
Jan 23, 2026
Exercise(M)
Direct
10K shares at avg. $2.45$25K
FENC
FENNEC PHARMACEUTICALS INC.
Jan 15, 2026
Exercise(M)
Direct
10K shares at avg. $2.45$25K
FENC
FENNEC PHARMACEUTICALS INC.
Jan 7, 2026
Exercise(M)
Direct
14.2K shares at avg. $2.45$35K
FENC
FENNEC PHARMACEUTICALS INC.
Dec 31, 2025
Award(A)
Direct
1.4K shares-
FENC
FENNEC PHARMACEUTICALS INC.
Dec 1, 2025
Award(A)
Direct
2.4K shares-
FENC
FENNEC PHARMACEUTICALS INC.
Oct 31, 2025
Award(A)
Direct
2.4K shares-
FENC
FENNEC PHARMACEUTICALS INC.
Sep 30, 2025
Award(A)
Direct
2.4K shares-

		Type	Shares	Price		Ownership
Oct 31, 2026	FENC FENNEC PHARMACEUTICALS INC.	Award(A)	1,703	-	$0	Direct
Oct 12, 2026	FENC FENNEC PHARMACEUTICALS INC.	Award(A)	3,846	$5.53	$21,268	Direct
Sep 30, 2026	FENC FENNEC PHARMACEUTICALS INC.	Award(A)	1,703	-	$0	Direct
Aug 28, 2026	FENC FENNEC PHARMACEUTICALS INC.	Exercise(M)	21,928	$5.10	$111,833	Direct
Aug 27, 2026	FENC FENNEC PHARMACEUTICALS INC.	Sale(S)	75,000	$11.78	$883,500	Direct
Jul 31, 2026	FENC FENNEC PHARMACEUTICALS INC.	Award(A)	1,703	-	$0	Direct
Jun 30, 2026	FENC FENNEC PHARMACEUTICALS INC.	Award(A)	1,703	-	$0	Direct
May 31, 2026	FENC FENNEC PHARMACEUTICALS INC.	Award(A)	1,703	-	$0	Direct
Apr 30, 2026	FENC FENNEC PHARMACEUTICALS INC.	Exercise(M)	1,703	-	$0	Direct
Mar 31, 2026	FENC FENNEC PHARMACEUTICALS INC.	Award(A) Stock Options	120,000	$5.77	-	Direct
Mar 31, 2026	FENC FENNEC PHARMACEUTICALS INC.	Exercise(M)	2,213	-	$0	Direct
Mar 31, 2026	FENC FENNEC PHARMACEUTICALS INC.	Exercise(M)	14,724	-	$0	Direct
Mar 28, 2026	FENC FENNEC PHARMACEUTICALS INC.	Exercise(M)	12,270	-	$0	Direct
Mar 26, 2026	FENC FENNEC PHARMACEUTICALS INC.	Exercise(M)	13,072	$5.10	$66,667	Direct
Feb 28, 2026	FENC FENNEC PHARMACEUTICALS INC.	Award(A)	1,191	-	$0	Direct
Feb 18, 2026	FENC FENNEC PHARMACEUTICALS INC.	Exercise(M)	2,450	$4.08	$9,996	Direct
Feb 18, 2026	FENC FENNEC PHARMACEUTICALS INC.	Exercise(M)	27,285	-	$0	Direct
Jan 31, 2026	FENC FENNEC PHARMACEUTICALS INC.	Award(A)	1,558	-	$0	Direct
Jan 23, 2026	FENC FENNEC PHARMACEUTICALS INC.	Exercise(M)	10,000	$2.45	$24,500	Direct
Jan 15, 2026	FENC FENNEC PHARMACEUTICALS INC.	Exercise(M)	10,000	$2.45	$24,500	Direct
Jan 7, 2026	FENC FENNEC PHARMACEUTICALS INC.	Exercise(M)	14,184	$2.45	$34,751	Direct
Dec 31, 2025	FENC FENNEC PHARMACEUTICALS INC.	Award(A)	1,382	-	$0	Direct
Dec 1, 2025	FENC FENNEC PHARMACEUTICALS INC.	Award(A)	2,430	-	-	Direct
Oct 31, 2025	FENC FENNEC PHARMACEUTICALS INC.	Award(A)	2,430	-	-	Direct
Sep 30, 2025	FENC FENNEC PHARMACEUTICALS INC.	Award(A)	2,430	-	-	Direct

1-25 of 43 transactions

About Andrade Robert

Andrade Robert (SEC CIK 0001468308) files insider reports with the SEC as CHIEF FINANCIAL OFFICER of FENNEC PHARMACEUTICALS INC. (FENC).

Signal8 holds 37 ownership filings by Andrade Robert, all Form 4s, filed between Sep 4, 2024 and Nov 2, 2026. Those filings report 43 transactions, from Aug 31, 2024 to Oct 31, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Andrade Robert's filings is in RESEARCH TRIANGLE PARK, NC.

Recent filings by Andrade Robert

Oct 31, 2026: Grant or award of FENC shares (Form 4, code A).
Oct 12, 2026: Grant or award of FENC shares (Form 4, code A).
Sep 30, 2026: Grant or award of FENC shares (Form 4, code A).
Aug 28, 2026: Option exercise of FENC shares (Form 4, code M).
Aug 27, 2026: Open-market sale of FENC shares (Form 4, code S).

Other insiders filing for FENNEC PHARMACEUTICALS INC. (FENC)

Evans Terry L, Chief Commercial Officer
Sayad Pierre Sargis, Chief Medical Officer
Hackman Jeffrey S., Chief Executive Officer
Cioffi Christiana Marie, Chief Strategy Officer
Brughera Marco Maria, Director
Raykov Rosty, Officer

How to read Form 4 transaction codes